SLDB Stock Analysis: Buy, Sell, or Hold?
SLDB - Solid Biosciences Inc. Common Stock
$10.84
0.64 (6.27%)
▲
5d:
+22.35%
30d:
+64.74%
90d:
+46.88%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When SLDB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SLDB is 19.1% above its trading range ($9.10). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SLDB is 19.1% above its trading range ($9.10). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: SLDB is currently trading at $10.84, which is considered extended relative to its 30-day fair value range of $6.59 to $9.10.
Technical Outlook: Technically, SLDB is in a uptrend. The price is approaching resistance at $10.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: SLDB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.38 (+60.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SLDB is in a uptrend. The price is approaching resistance at $10.88. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: SLDB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.38 (+60.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.59 -
$9.10
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price significantly overextended (+19.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 60.4% below Wall St target ($17.38)
- WARNING: Recommendation downgraded due to 19.1% overvaluation
Trading Range Analysis
30-Day Trading Range
$6.59 -
$9.10
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.49
Resistance Level
$10.88
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.54
Wall Street Target
$17.38
(+60.4%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 03, 2026 10:31 PM ET
Data refreshes hourly during market hours. Next update: 11:31 PM
Data refreshes hourly during market hours. Next update: 11:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLDB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Howton
SELL
7469 shares
2026-02-18
Ilan Ganot
SELL
2658 shares
2026-02-18
Jessie Hanrahan
SELL
4134 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 67 BUY |
